Sign Up to like & get
recommendations!
1
Published in 2021 at "ACS infectious diseases"
DOI: 10.1021/acsinfecdis.1c00501
Abstract: Despite the advances in β-lactamase inhibitor development, limited options exist for the class D carbapenemase known as OXA-48. OXA-48 is one of the most prevalent carbapenemases in carbapenem-resistant Enterobacteriaceae infections and is not susceptible to…
read more here.
Keywords:
inhibit oxa;
inhibitor development;
escherichia coli;
carbapenemase ... See more keywords